April 29, 2024
Investors

ROBLOX SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS

NEW ORLEANS, Jan. 02, 2024 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 26, 2024 to file lead plaintiff applications in a securities class action lawsuit against Roblox Corporation (NYSE: RBLX), if they purchased or otherwise acquired the Company’s shares between March 10, 2021 and February 15, 2022,

Read More
Investors

UBS Downgrades Li-Cycle Holdings (LICY) Amid Investor

SAN FRANCISCO, Dec. 31, 2023 (GLOBE NEWSWIRE) — Hagens Berman urges Li-Cycle Holdings Corp. (NYSE: LICY) investors who suffered substantial losses to submit your losses now. Class Period: June 14, 2022 – Oct. 23, 2023Lead Plaintiff Deadline: Jan. 8, 2024Visit: www.hbsslaw.com/investor-fraud/LICY Contact An Attorney Now: LICY@hbsslaw.com 844-916-0895 Li-Cycle Holdings Corp. (NYSE: LICY) Securities Fraud Class

Read More
Investors

GNRC SHAREHOLDER ALERT: ROSEN, LEADING INVESTOR COUNSEL,

NEW YORK, Dec. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Generac Holdings Inc. (NYSE: GNRC) between May 3, 2023 and August 3, 2023, both dates inclusive (the “Class Period”), of the important January 22, 2024 lead plaintiff deadline. SO WHAT: If you

Read More
Investors

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Expensify, Inc.

NEW YORK, Dec. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Expensify, Inc. (NASDAQ: EXFY) pursuant and/or traceable to the Offering Documents issued in connection with the Company’s Initial Public Offering conducted on or about November 11, 2021 (“IPO” or “Offering”), of

Read More
Investors

Robbins Geller Rudman & Dowd LLP

SAN DIEGO, Dec. 30, 2023 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Driven Brands Holdings Inc. (NASDAQ: DRVN) common stock between October 27, 2021 and August 1, 2023, both dates inclusive (the “Class Period”), have until February 20, 2024 to seek appointment as lead plaintiff

Read More
Investors

Bragar Eagel & Squire, P.C. Reminds Investors That Class

NEW YORK, Dec. 29, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Beauty Health Company (NASDAQ: SKIN), and NuScale Power Corporation (NYSE: SMR). Stockholders have until the deadlines below to petition the court to

Read More
Investors

Investors Allege NuScale (SMR) Concealed Facts About Now

SAN FRANCISCO, Dec. 29, 2023 (GLOBE NEWSWIRE) — Hagens Berman urges NuScale Power Corporation (NYSE: SMR) investors who suffered substantial losses to submit your losses now. Class Period: Mar. 15, 2023 – Nov. 8, 2023Lead Plaintiff Deadline: Jan. 16, 2024Visit: www.hbsslaw.com/investor-fraud/SMR Contact An Attorney Now: SMR@hbsslaw.com                         

Read More
Investors

January 2. 2024 Lawsuit Deadline: Investors who lost over

SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) — The Shareholders Foundation, Inc. announces that a deadline is coming up in the lawsuit filed for certain investors in shares of Outlook Therapeutics, Inc. (NASDAQ: OTLK). Investors, who lost more than $200,000 with shares of Outlook Therapeutics, Inc. (NASDAQ: OTLK), have certain options and there are short

Read More
Investors

XPOF LOSS ALERT: ROSEN, NATIONALLY REGARDED INVESTOR

NEW YORK, Dec. 25, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Xponential Fitness, Inc. (NYSE: XPOF) resulting from allegations that Xponential Fitness may have issued materially misleading business information to the investing public. SO WHAT: If you purchased

Read More
Investors

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell

NEW YORK, Dec. 25, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and September 27, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline in the securities

Read More